Viracta Therapeutics News

Viracta Therapeutics | 8-K: Current report

May 15 04:40

Viracta Therapeutics | 8-K: Viracta Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update

May 10 04:41

Viracta Therapeutics | DEFA14A: Others

Apr 27 04:28

Viracta Therapeutics | DEF 14A: Definitive information statements

Apr 27 04:10

Viracta Therapeutics | 8-K: Current report

Apr 10 04:35

Viracta Therapeutics | 8-K: Current report

Mar 21 04:48

Viracta Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Mar 8 06:06

Viracta Therapeutics | 8-K: Viracta Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Mar 8 05:16

Viracta Therapeutics | 8-K: Current report

Nov 18, 2023 06:30

Viracta Therapeutics | 8-K: Viracta Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update

Nov 9, 2023 21:30

Viracta Therapeutics | 8-K: Current report

Oct 4, 2023 19:01

Viracta Therapeutics | 8-K: Viracta Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update

Aug 14, 2023 20:02

Viracta Therapeutics | 8-K: Current report

Aug 7, 2023 19:36

Viracta Therapeutics | 8-K: Current report

Jun 10, 2023 04:53

Viracta Therapeutics | 8-K: Viracta Therapeutics Reports First Quarter 2023 Financial Results and Provides Clinical Program Updates

May 9, 2023 04:23

Viracta Therapeutics | 8-K/A: Current report (Amendment)

May 6, 2023 04:52

Viracta Therapeutics | 8-K: Current report

May 3, 2023 04:33

Viracta Therapeutics | DEFA14A: Others

Apr 28, 2023 04:03

Viracta Therapeutics | DEF 14A: Definitive proxy statements

Apr 28, 2023 04:01

Viracta Therapeutics | 8-K: Current report

Apr 1, 2023 04:31